Seroatlas · Human Serome Atlas

PEPD

Xaa-Pro dipeptidase

Also known as: PEPD_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P12955
Gene
PEPD
Ensembl
ENSG00000124299
Chromosome
19
Canonical length
493 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes a member of the peptidase family. The protein forms a homodimer that hydrolyzes dipeptides or tripeptides with C-terminal proline or hydroxyproline residues. The enzyme serves an important role in the recycling of proline, and may be rate limiting for the production of collagen. Mutations in this gene result in prolidase deficiency, which is characterized by the excretion of large amount of di- and tri-peptides containing proline. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]

Canonical amino-acid sequenceUniProt

493 residues, UniProt reviewed canonical sequence.

>P12955|PEPD
     1  MAAATGPSFW LGNETLKVPL ALFALNRQRL CERLRKNPAV QAGSIVVLQG GEETQRYCTD
    61  TGVLFRQESF FHWAFGVTEP GCYGVIDVDT GKSTLFVPRL PASHATWMGK IHSKEHFKEK
   121  YAVDDVQYVD EIASVLTSQK PSVLLTLRGV NTDSGSVCRE ASFDGISKFE VNNTILHPEI
   181  VECRVFKTDM ELEVLRYTNK ISSEAHREVM KAVKVGMKEY ELESLFEHYC YSRGGMRHSS
   241  YTCICGSGEN SAVLHYGHAG APNDRTIQNG DMCLFDMGGE YYCFASDITC SFPANGKFTA
   301  DQKAVYEAVL RSSRAVMGAM KPGVWWPDMH RLADRIHLEE LAHMGILSGS VDAMVQAHLG
   361  AVFMPHGLGH FLGIDVHDVG GYPEGVERID EPGLRSLRTA RHLQPGMVLT VEPGIYFIDH
   421  LLDEALADPA RASFLNREVL QRFRGFGGVR IEEDVVVTDS GIELLTCVPR TVEEIEACMA
   481  GCDKAFTPFS GPK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PEPD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.23
Highest tissue expression
310 nTPM

Expression across tissuesHPA

Tissue

  • kidney: 310 nTPM
  • small intestine: 201 nTPM
  • duodenum: 172 nTPM
  • liver: 110 nTPM
  • spinal cord: 58 nTPM
  • adrenal gland: 53 nTPM

Single-cell type

  • enterocytes: 850 nCPM
  • hofbauer cells: 395 nCPM
  • hepatocytes: 210 nCPM
  • proximal tubule cells: 197 nCPM
  • adipocytes: 173 nCPM
  • esophageal suprabasal cells: 173 nCPM

Immune cell

  • intermediate monocyte: 122 nTPM
  • total PBMC: 118 nTPM
  • classical monocyte: 115 nTPM
  • basophil: 112 nTPM
  • myeloid DC: 99 nTPM
  • non-classical monocyte: 92 nTPM

Brain region

  • white matter: 68 nTPM
  • spinal cord: 52 nTPM
  • cerebellum: 49 nTPM
  • medulla oblongata: 47 nTPM
  • basal ganglia: 45 nTPM
  • choroid plexus: 44 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about PEPD.

Disease | AllUniProt

Conditions PEPD is implicated in, by any mechanism.

Disease | GeneticClinVar

79 pathogenic / likely-pathogenic of 816 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.26
gnomAD pLI
0
gnomAD missense Z
-0.18
DepMap mean gene effect
0.01
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PEPD as an antibody target. Whether an autoantibody or antibody against PEPD could matter depends on whether native PEPD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PEPD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label PEPD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PEPD. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...